Cigna CorporationCINYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +28.44% | +14.40% | +11.08% | +9.50% | +10.39% |
| Gross Profit Growth | -1.69% | +3.48% | +21.03% | -10.03% | -14.05% |
| EBITDA Growth | -6.25% | +0.82% | -5.18% | +1.37% | -13.50% |
| Operating Income Growth | +5.49% | -12.63% | +0.83% | +0.08% | -1.15% |
| Net Income Growth | +38.39% | +0.00% | -1.03% | +152.77% | -13.34% |
| EPS Growth | +46.99% | +0.00% | +4.54% | +164.91% | -9.55% |
| EPS Diluted Growth | +46.99% | +0.00% | +4.77% | +165.02% | -9.55% |
| Weighted Average Shares Growth | -5.70% | -2.15% | -5.32% | -4.41% | -4.26% |
| Weighted Average Shares Diluted Growth | -5.70% | -1.13% | -5.60% | -4.71% | -4.26% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +255.28% | -60.33% | -811.70% | +7330.43% | +17.98% |
| Free Cash Flow Growth | +342.38% | -64.91% | +0.00% | +0.00% | +19.53% |
| Receivables Growth | +37.91% | +29.04% | +25.49% | +13.87% | +19.54% |
| Inventory Growth | +18.55% | +11.79% | +15.35% | +10.80% | +9.65% |
| Asset Growth | +2.04% | -1.61% | -2.44% | +0.18% | +1.31% |
| Book Value per Share Growth | -5.87% | -0.17% | +2.76% | +3.89% | +6.18% |
| Debt Growth | +3.37% | -7.08% | -3.52% | +3.77% | -1.59% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -0.19% | +3.57% | -5.37% | -4.54% | -9.00% |